Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences Novartis will pay UK ...
New York Mets owner and billionaire investor Steven Cohen is known for a high-risk/reward investing approach. He founded the now-defunct ...
In a field where innovation meets regulation, Carol Houston, founder of BaysMartin Consulting, understands the delicate balance between them. With ...
Mainland retail traders are being lured by the outperformance of the city’s equities, combined with their accessibility and abundance of ...
Novartis agreed to buy Tourmaline Bio in a deal valued at about US$1.4 billion as the Swiss drugmaker continues to ...
Higher revenue is driven by increased contributions from its early detection and precision multi-omics segment Local biotech startup Mirxes on ...
While the Melbourne-based company employs around 32,000 people, no firm number was put on the job cuts Published Tue, Aug ...
For Tiffani Griffith, CEO of Lord & Griffith Consulting, executive search is more than just filling a position; it's about ...
China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and ...
Published Tue, Jun 3, 2025 · 07:45 AMMERCK has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than ...
